Detalhe da pesquisa
1.
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Blood
; 118(23): 6043-9, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21967976
2.
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.
Cancer Chemother Pharmacol
; 92(1): 15-28, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219686
3.
Clofarabine in pediatric acute leukemia: current findings and issues.
Pediatr Blood Cancer
; 59(3): 417-22, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22354543
4.
The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions.
J Clin Oncol
; 40(29): 3456, 2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947814
5.
ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
Eur J Cancer
; 166: 145-164, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290915
6.
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 177: 120-142, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335782
7.
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
Lancet Oncol
; 11(10): 950-61, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20850381
8.
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.
Paediatr Drugs
; 23(4): 381-394, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173206
9.
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Eur J Cancer
; 157: 198-213, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536944
10.
Tolerability of pravastatin in pediatric hematopoietic stem cell transplant patients with bronchiolitis obliterans.
J Pediatr Hematol Oncol
; 32(3): 185-8, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20186101
11.
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 136: 116-129, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688206
12.
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
Eur J Cancer
; 127: 52-66, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31986450
13.
Population Pharmacokinetics of Gemtuzumab Ozogamicin in Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Clin Pharmacokinet
; 58(2): 271-282, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30022367
14.
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias.
Clin Lymphoma Myeloma Leuk
; 17(10): 684-695.e6, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807791
15.
Acute lymphoblastic leukemia in adolescents and young adults.
Curr Hematol Malig Rep
; 3(3): 161-6, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20425461
16.
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
J Clin Oncol
; 26(7): 1106-11, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18309945
17.
Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management.
Expert Opin Pharmacother
; 8(8): 1039-58, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17516870
18.
Uniform sensitivity of FLT3 activation loop mutants to the tyrosine kinase inhibitor midostaurin.
Blood
; 110(13): 4476-9, 2007 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17827387
19.
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
J Clin Oncol
; 25(7): 813-9, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17327603